Number of the records: 1  

2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein

  1. 1.
    SYSNO ASEP0580601
    Document TypeP - Patent
    R&D Document TypePatent or other outcome protected by special legislation
    Title2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
    Author(s) Birkuš, Gabriel (UOCHB-X) ORCID
    Páv, Ondřej (UOCHB-X) RID, ORCID
    Jandušík, Tomáš (UOCHB-X) ORCID
    Rosenberg, Ivan (UOCHB-X) RID, ORCID
    Nencka, Radim (UOCHB-X) RID, ORCID
    Year of issue2023
    Possible third party use of the resultA - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence
    Royalty requestedA - Poskytovatel licence požaduje licenční poplatek
    Patent no. or utility model no. or industrial design no.EP3728282
    Date of the patent acceptance22.11.2023
    Name of the patent ownerÚstav organické chemie a biochemie AV ČR, v. v. i
    Code of the issuer nameEPO_1 - European Patent Office Munich, The Hague, Berlin, Vienna, Brusselshttp://www.epo.org/
    Current useA - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem
    Territorial ProtectionEPC - evropský patent podle Evropské patentové úmluvy
    PCT - mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci
    Languageeng - English
    KeywordsSTING ; cyclic dinucleotide ; agonist
    OECD categoryOrganic chemistry
    R&D ProjectsEF16_019/0000729 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUOCHB-X - RVO:61388963
    AnnotationThe present disclosure relates to 2′3′ cyclic phosphonate dinucleotides of general formula (J), their pharmaceutically acceptable salts, their pharmaceutical composition and combinations of said substances and other medicaments or pharmaceuticals. The disclosure also relates to the use of said compounds for the treatment or prevention of diseases or conditions modifiable by STING protein modulation, such as cancer or viral, allergic and inflammatory diseases. In addition, these substances can be used as adjuvants in vaccines.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2024
    Electronic addresshttps://worldwide.espacenet.com/patent/search/family/065244413/publication/EP3728282B1?q=EP3728282B1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.